MLANA antibody (AA 1-37) (FITC)
Quick Overview for MLANA antibody (AA 1-37) (FITC) (ABIN8008808)
Target
See all MLANA AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 1-37
-
Purpose
- Anti-Melan-A/MLANA Antibody FITC Conjugated
-
Cross-Reactivity (Details)
- No cross-reactivity with other proteins.
-
Purification
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human Melan-A/MLANA recombinant protein (Position: M1-L37).
-
Isotype
- IgG
-
-
-
-
Application Notes
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Expiry Date
- 12 months
-
-
- MLANA (Melan A (MLANA))
-
Alternative Name
- MLANA
-
Background
-
Background: MLANA (Melan-A, also known as MART1, MART-1), located on 9p24.1, is a Protein Coding gene. The gene produces a 13157 Da protein composed of 118 amino acids. MLANA is a hydrophobic transmembrane protein without glycosylation sites highly enriched in early melanosomes. MLANA is expressed in skin and retinae melanocytes and the majority of melanoma tumors, but it is absent from other tissues and tumors. Diseases such as Melanoma In Congenital Melanocytic Nevus and Angiomyolipoma are associated with MLANA. The related pathways of MLANA include NF-kappaB Signaling.
Gene Full Name: melan-A
-
Gene ID
- 2315
-
UniProt
- Q16655
Target
-